GBLX实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (27 Apr 2024 @ 03:08):

Stats
今日成交量	81 311.00
平均成交量	123 712
市值	2.72M
EPS	$0 ( 2024-02-02 )
下一个收益日期	( $0 ) 2024-07-12
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.670
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2018-07-11	Poss John C	Buy	3 615	Common Stock
2018-07-11	Poss John C	Buy	11 915	Common Stock
2018-07-11	Poss John C	Buy	20 000	Common Stock
2018-07-11	Poss John C	Buy	1 250	Common Stock
2018-07-11	Poss John C	Buy	30 000	Common Stock

INSIDER POWER
0.00
Last 84 transactions
Buy: 3 790 243 \| Sell: 13 501 701

GB Sciences, Inc. 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

GB Sciences, Inc. 财务报表

Annual	2022
营收:	$0
毛利润:	$-61 660.00 (0.00 %)
EPS:	$-7 356.48

FY	2022
营收:	$0
毛利润:	$-61 660.00 (0.00 %)
EPS:	$-7 356.48

FY	2022
营收:	$0
毛利润:	$0 (0.00 %)
EPS:	$0.00520

FY	2021
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-0.0133

Financial Reports:

No articles found.

GB Sciences, Inc.

GB Sciences, Inc. engages in the research and development of plant-based medicines in North America and Europe. The company offers cannabinoid-inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and cardiovascular therapeutic programs. The company was formerly known as Growblox Sciences, Inc. and changed its name to GB Sciences, Inc. in October 2016. GB Sciences, Inc. was incorporated in 2001 and is based in Las Vegas, Nevada.